NRP1 and neoplasm: Nevertheless, targeting NRP1 could be a potential approach to preventing SARS-CoV-2 entry [21,22] and for developing potential anti-tumor drugs [23,24], with a peptide-based inhibition in anti-angiogenesis, anti-proliferation, and anti-migration of tumor cells [25].